TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
-8.6%/yr
Annual compound
5Y CAGR
+56.9%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
9.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.32M | +266.7% |
| 2024 | $2.82M | -86.6% |
| 2023 | $21.05M | +55.5% |
| 2022 | $13.54M | +33.5% |
| 2021 | $10.14M | +834.7% |
| 2020 | $1.08M | - |
| 2019 | $0.00 | - |